Targeted Therapy Clinical Trials
0 recruiting
Showing 1–5 of 5 trials
Recruiting
Phase 2
SCRT Followed by CAPOX + Bev ± PD-1 Inhibitor for TNT in LARC
Rectal CancerRectal AdenocarcinomaTargeted Therapy+6 more
Ruijin Hospital104 enrolled1 locationNCT07198165
Recruiting
Phase 2
Oral Chemotherapy, Targeted Therapy and Immunotherapy With/Without Radiotherapy as 3rd- or Later-line Therapy for Advanced MSS/pMMR Colorectal Cancer
ChemotherapyTargeted TherapyImmunotherapy+2 more
Sun Yat-sen University57 enrolled1 locationNCT06764680
Recruiting
Real-world Study on the Management of Hematological Toxicities Associated With Targeted Therapies for Breast Cancer
Breast CancerTargeted TherapyHematological Toxicity
Fudan University1,000 enrolled1 locationNCT06503380
Recruiting
RecistTM Criteria in Evaluating the Efficacy of Targeted Therapy for NSCLC
NSCLCTargeted TherapyEvaluation
Xueqin Yang44 enrolled1 locationNCT06142058
Recruiting
Phase 2
Chidamide/Everolimus for PIK3CA Wild-type/Mutant HR+/HER2- Advanced Breast Cancer
HR+/HER2- Advanced Breast CancerTargeted Therapy
Cancer Institute and Hospital, Chinese Academy of Medical Sciences102 enrolled1 locationNCT05983107